TTN mutation has been reported to be correlated with myopathy and cancer, and one study showed that lncRNA TTN-AS1, which is transcribed in the opposite direction of TTN, was upregulated in ccRCC samples and positive associated with poor clinicopathological performances (51). This evidence concerns the gene TTN and cancer.